Canada · Health Canada Drug Product Database

SWICAL EXTRA-FORT

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
59871
DIN
02236397
Form
Tablet
Company as listed by source
LES LABORATOIRES SUISSE INC.
Source status
Cancelled Pre Market (2017-08-31)
Source last updated
2025-03-22

Source-listed ingredients

  • CALCIUM (CALCIUM CITRATE, CALCIUM CARBONATE, CALCIUM PHOSPHATE) — 600 MG
  • MAGNESIUM (MAGNESIUM CITRATE, MAGNESIUM OXIDE) — 100 MG
  • VITAMIN D3 — 200 UNIT
  • PHOSPHORUS (CALCIUM PHOSPHATE) — 100 MG
  • SILICON (SILICON DIOXIDE) — 5 MG
  • ZINC (ZINC GLUCONATE) — 5 MG
  • FLUORINE (CALCIUM FLUORIDE) — 0.05 MG

These values do not establish equivalence or a dose recommendation.

Packages

Package details are not available in this snapshot.

Source and coverage

Open Health Canada Drug Product Database

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse Canada records →